Carmel Jacobs

687 total citations
32 papers, 483 citations indexed

About

Carmel Jacobs is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Carmel Jacobs has authored 32 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Carmel Jacobs's work include Bone health and treatments (8 papers), Cancer Diagnosis and Treatment (7 papers) and Breast Cancer Treatment Studies (6 papers). Carmel Jacobs is often cited by papers focused on Bone health and treatments (8 papers), Cancer Diagnosis and Treatment (7 papers) and Breast Cancer Treatment Studies (6 papers). Carmel Jacobs collaborates with scholars based in Canada, United States and New Zealand. Carmel Jacobs's co-authors include Brian Hutton, Mark Clemons, Risa Shorr, Mark Clemons, Sasha Mazzarello, Terry L. Ng, Mohammed Ibrahim, Stephanie Smith, Michael Ong and Demetrios Simos and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Carmel Jacobs

31 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmel Jacobs Canada 13 259 90 86 72 66 32 483
Pooja Ramakant India 12 240 0.9× 223 2.5× 49 0.6× 48 0.7× 161 2.4× 59 759
Gurdeep Mannu United Kingdom 13 176 0.7× 173 1.9× 93 1.1× 52 0.7× 191 2.9× 45 639
Janet Colli United States 15 132 0.5× 122 1.4× 196 2.3× 51 0.7× 96 1.5× 40 577
Juan Antonio Virizuela Spain 12 231 0.9× 127 1.4× 165 1.9× 32 0.4× 78 1.2× 57 587
Geneviève Macquart‐Moulin France 10 311 1.2× 80 0.9× 100 1.2× 243 3.4× 79 1.2× 16 701
Kunal C. Kadakia United States 13 208 0.8× 93 1.0× 90 1.0× 42 0.6× 45 0.7× 43 455
Aimee Faso United States 7 152 0.6× 95 1.1× 70 0.8× 68 0.9× 32 0.5× 8 541
Niloofar Ahmadloo Iran 15 177 0.7× 132 1.5× 116 1.3× 18 0.3× 40 0.6× 69 590
Güzin Gönüllü Türkiye 12 196 0.8× 65 0.7× 66 0.8× 43 0.6× 86 1.3× 23 467
Nynke Zwart Netherlands 16 194 0.7× 159 1.8× 138 1.6× 66 0.9× 66 1.0× 25 648

Countries citing papers authored by Carmel Jacobs

Since Specialization
Citations

This map shows the geographic impact of Carmel Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmel Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmel Jacobs more than expected).

Fields of papers citing papers by Carmel Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmel Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmel Jacobs. The network helps show where Carmel Jacobs may publish in the future.

Co-authorship network of co-authors of Carmel Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Carmel Jacobs. A scholar is included among the top collaborators of Carmel Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmel Jacobs. Carmel Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chacón, Matías, Sergio Bracarda, Marco Maruzzo, et al.. (2022). Subcutaneous nivolumab versus intravenous nivolumab in patients with previously treated, advanced, or metastatic clear cell renal cell carcinoma.. Journal of Clinical Oncology. 40(16_suppl). TPS4621–TPS4621. 2 indexed citations
2.
3.
Fu, Simon, et al.. (2018). Real world experience of docetaxel in elderly patients with advanced prostate cancer.. Journal of Clinical Oncology. 36(6_suppl). 313–313. 1 indexed citations
4.
Jacobs, Carmel, Mark Clemons, Sasha Mazzarello, et al.. (2017). Enhancing accrual to chemotherapy trials for patients with early stage triple-negative breast cancer: a survey of physicians and patients. Supportive Care in Cancer. 25(6). 1881–1886. 8 indexed citations
5.
LeVasseur, Nathalie, Mark Clemons, Brian Hutton, Risa Shorr, & Carmel Jacobs. (2016). Bone-targeted therapy use in patients with bone metastases from lung cancer: A systematic review of randomized controlled trials. Cancer Treatment Reviews. 50. 183–193. 36 indexed citations
6.
Jacobs, Carmel, Anil A. Joy, Mark Clemons, Sasha Mazzarello, & Michael Fralick. (2016). Training the Trainer: Five Practical Considerations for Your First Five Years in Practice. Current Oncology. 23(2). 71–73. 5 indexed citations
7.
Fernandes, Ricardo, Sasha Mazzarello, Brian Hutton, et al.. (2016). Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review. Supportive Care in Cancer. 24(8). 3633–3650. 37 indexed citations
8.
Fernandes, Ricardo, Sasha Mazzarello, Brian Hutton, et al.. (2016). A Systematic Review of the Incidence and Risk Factors for Taxane Acute Pain Syndrome in Patients Receiving Taxane-Based Chemotherapy for Prostate Cancer. Clinical Genitourinary Cancer. 15(1). 1–6. 12 indexed citations
9.
Jacobs, Carmel, Eitan Amir, Alexander Paterson, Xiaofu Zhu, & Mark Clemons. (2015). Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting. Journal of bone oncology. 4(2). 54–58. 16 indexed citations
10.
Fernandes, Ricardo, Sasha Mazzarello, Habeeb Majeed, et al.. (2015). Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy—a systematic review. Supportive Care in Cancer. 24(4). 1583–1594. 28 indexed citations
11.
Mazzarello, Sasha, Mark Clemons, Carmel Jacobs, Amel Arnaout, & Michael Fralick. (2015). Publishing Clinical Research: Ten Pearls for Oncology Trainees and Junior Oncologists. Current Oncology. 22(1). 1–5. 4 indexed citations
12.
Jacobs, Carmel, Brian Hutton, Sasha Mazzarello, et al.. (2015). Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy—a survey of health care providers and patients. Supportive Care in Cancer. 23(11). 3269–3275. 13 indexed citations
13.
Jacobs, Carmel, Mark Clemons, & Anil A. Joy. (2015). Oncologist Heal Thyself: Hallmarks of Happiness. Current Oncology. 22(6). 415–418. 2 indexed citations
14.
Mazzarello, Sasha, et al.. (2015). Third-Party Online Surveys—Science, Selling, or Sugging?. Current Oncology. 22(3). 182–183. 5 indexed citations
15.
Mazzarello, Sasha, Brian Hutton, Mohammed Ibrahim, et al.. (2015). Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials. Breast Cancer Research and Treatment. 152(1). 1–8. 29 indexed citations
16.
17.
Jacobs, Carmel, Mark Clemons, Brian Hutton, et al.. (2015). Treatment choices for patients with invasive lobular breast cancer: a doctor survey. Journal of Evaluation in Clinical Practice. 21(4). 740–748. 14 indexed citations
18.
Jacobs, Carmel, Demetrios Simos, Christina Addison, Mohammed Ibrahim, & Mark Clemons. (2014). Pharmacotherapy of bone metastases in breast cancer patients – an update. Expert Opinion on Pharmacotherapy. 15(8). 1109–1118. 10 indexed citations
19.
Jacobs, Carmel, Ian D. Graham, Julie Makarski, et al.. (2014). Clinical Practice Guidelines and Consensus Statements in Oncology – An Assessment of Their Methodological Quality. PLoS ONE. 9(10). e110469–e110469. 35 indexed citations
20.
Jacobs, Carmel, Iryna Kuchuk, Stephanie Smith, et al.. (2014). A randomized, double-blind trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronate in patients with high-risk bone metastases from breast cancer (The Odyssey Study).. Journal of Clinical Oncology. 32(31_suppl). 155–155. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pooja Ramakant Breakdown of academic impact, for papers by Gurdeep Mannu Breakdown of academic impact, for papers by Janet Colli Breakdown of academic impact, for papers by Juan Antonio Virizuela Breakdown of academic impact, for papers by Geneviève Macquart‐Moulin Breakdown of academic impact, for papers by Kunal C. Kadakia Breakdown of academic impact, for papers by Aimee Faso Breakdown of academic impact, for papers by Niloofar Ahmadloo Breakdown of academic impact, for papers by Güzin Gönüllü Breakdown of academic impact, for papers by Nynke Zwart
Rankless by CCL
2026